Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,644 USD | +6,25% | +2,77% | -52,73% |
Omzet 2024 * | 3K 2,8K | Omzet 2025 * | 2,5 mln. 2,34 mln. | Marktkapitalisatie | 21,75 mln. 20,33 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -68 mln. -63,57 mln. | Nettowinst (verlies) 2025 * | -77 mln. -71,99 mln. | EV/omzet 2024 * | 7.250 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 8,69 x |
K/w-verhouding 2024 * |
-0,42
x | K/w-verhouding 2025 * |
-0,48
x | Werknemers | 58 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,11% |
Recentste transcriptie over Biora Therapeutics, Inc.
1 dag | +6,25% | ||
1 week | +2,77% | ||
Lopende maand | -41,98% | ||
1 maand | -47,69% | ||
3 maanden | -34,27% | ||
6 maanden | -73,84% | ||
Lopend jaar | -52,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Adi Mohanty
CEO | Chief Executive Officer | 57 | 08-11-21 |
Eric d'Esparbes
DFI | Director of Finance/CFO | 56 | 01-05-19 |
Ariella Kelman
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 49 | 01-06-14 | |
Jeffrey Alter
CHM | Chairman | 61 | 01-01-19 |
Adi Mohanty
CEO | Chief Executive Officer | 57 | 08-11-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 0,6382 | +5,30% | 81 454 |
22-04-24 | 0,6061 | -1,45% | 160 218 |
19-04-24 | 0,615 | +2,59% | 105 736 |
18-04-24 | 0,5995 | -6,63% | 519 543 |
17-04-24 | 0,6421 | +3,40% | 317 789 |
uitgestelde koers Nasdaq, 23 april 2024 om 16:16 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-52,73% | 21,75 mln. | |
-0,57% | 103 mld. | |
+3,60% | 96,73 mld. | |
+1,48% | 21,31 mld. | |
-15,70% | 21,21 mld. | |
-6,26% | 18,79 mld. | |
-42,14% | 16,37 mld. | |
-22,43% | 13,68 mld. | |
+6,73% | 13,44 mld. | |
+24,02% | 10,98 mld. |